Related Experiment Video
Updated: May 3, 2026

5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
Published on: July 3, 2013
Maintenance of hypertensive hemodynamics does not depend on ROS in established experimental chronic kidney disease
Diana A Papazova1, Arianne van Koppen1, Maarten P Koeners1
1Department of Nephrology & Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands.
Insights
In chronic kidney disease (CKD), blood pressure and renal vascular resistance do not appear to depend on oxidative stress. This study found that reactive oxygen species are not key drivers of hypertension in established CKD.
Area of Science:
- Nephrology
- Cardiovascular Research
- Oxidative Stress
Background:
- Oxidative stress is prevalent in chronic kidney disease (CKD).
- The link between oxidative stress and hypertensive renal hemodynamics in CKD is not fully understood.
Purpose of the Study:
- To investigate if established CKD alters the dependence of blood pressure and renal vascular resistance on reactive oxygen species.
- To determine the role of oxidative stress in the hemodynamics of established hypertensive CKD.
Main Methods:
- CKD was induced in rats via bilateral kidney ablation.
- Mean arterial pressure (MAP), renal vascular resistance (RVR), and glomerular filtration rate (GFR) were measured.
- The effects of antioxidant (Tempol, PEG-catalase) or vehicle infusion on hemodynamics were assessed in CKD and control rats.
Main Results:
- CKD rats exhibited proteinuria, decreased GFR, elevated MAP, RVR, and oxidative stress markers.
- Antioxidants reduced MAP in controls but not significantly in CKD rats.
- While antioxidants affected RVR and sodium excretion, they did not normalize hypertension in CKD, suggesting a reduced dependence on reactive oxygen species.
Conclusions:
- Despite increased oxidative stress markers in CKD, mean arterial pressure and renal vascular resistance did not show a greater dependence on reactive oxygen species compared to controls.
- Reactive oxygen species are unlikely to be direct determinants of hypertensive renal hemodynamics in this model of established CKD.
Abstract:
While the presence of oxidative stress in chronic kidney disease (CKD) is well established, its relation to hypertensive renal hemodynamics remains unclear. We hypothesized that once CKD is established blood pressure and renal vascular resistance (RVR) no longer depend on reactive oxygen species. CKD was induced by bilateral ablation of 2/3 of each kidney. Compared to age-matched, sham-operated controls all ablated rats showed proteinuria, decreased glomerular filtration rate (GFR), more renal damage, higher mean arterial pressure (MAP), RVR and excretion of oxidative stress markers and hydrogen peroxide, while excretion of stable nitric oxide (NO) metabolites tended to decrease. We compared MAP, RVR, GFR and fractional excretion of sodium under baseline and during acute Tempol, PEG-catalase or vehicle infusion in rats with established CKD vs. controls. Tempol caused marked reduction in MAP in controls (96±5 vs.79±4 mmHg, P<0.05) but not in CKD (130±5 vs. 127±6 mmHg). PEG-catalase reduced MAP in both groups (controls: 102±2 vs. 94±4 mmHg, P<0.05; CKD: 118±4 vs. 110±4 mmHg, P<0.05), but did not normalize MAP in CKD rats. Tempol and PEG-catalase slightly decreased RVR in both groups. Fractional excretion of sodium was increased by both Tempol and PEG-catalase in both groups. PEG-catalase decreased TBARS excretion in both groups. In sum, although oxidative stress markers were increased, MAP and RVR did not depend more on oxidative stress in CKD than in controls. Therefore reactive oxygen species appear not to be important direct determinants of hypertensive renal hemodynamics in this model of established CKD.
Related Concept Videos
Hypertension and Regulation of Blood Pressure
Chronic Kidney Disease III: Interprofessional Care
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antihypertensive Drugs: Direct Renin Inhibitors
Heart Failure Drugs: Diuretics
Chronic Kidney Disease I: Introduction

